While specialty assays in these diagnostic areas tend to be processed manually or with semi-automated, low-throughput analyzers ... chief technical officer of EUROIMMUN. “Having been built ...

With this new ELISA assay, EUROIMMUN is providing a product to support careful evaluation of an important antibody subgroup enabling standard curve-based quantification of the anti-S1 IgG antibody ...

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 The Anti-SARS-CoV-2 S1 Curve ELISA (IgG) – based on EUROIMMUN’s ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), announced today that its EUROIMMUN business has launched the UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) ...

The exclusive research report on ‘ELISA Analyzer Market‘ now available with ????? ????? ?????, offers a detailed analysis of the factors influencing the global business sphere.

WALTHAM, Mass., March 03, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a ...

--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of its new IDS i20™ analytical random access platform from EUROIMMUN ... semi-automated, low-throughput analyzers ...

May 19, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of its new IDS i20™ analytical random access platform from EUROIMMUN, enabling full automation of ...